Pasireotide

Generic name: Pasireotide
Drug class: Somatostatin and somatostatin analogs

Usage of Pasireotide

Pasireotide is a man-made protein that is similar to a hormone in the body called somatostatin.

Pasireotide is used to treat Cushing's disease or acromegaly (endocrine disorders). Pasireotide is usually given after surgery or other treatments did not work or have stopped working.

Pasireotide may also be used for purposes not listed in this medication guide.

Pasireotide side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Pasireotide may cause serious side effects. Call your doctor at once if you have:

fast or slow heartbeats;

sudden dizziness (like you might pass out);

high blood sugar--increased thirst, increased urination, fruity breath odor, tiredness, and weight loss even if you are more hungry than usual;

ketoacidosis (too much acid in the blood)--nausea, vomiting, stomach pain, confusion, unusual drowsiness, or trouble breathing;

low cortisol levels--nausea, vomiting, appetite changes, headache, irritability, confusion, slurred speech, or feeling weak, tired, unsteady, anxious, shaky, or light-headed; or

gallbladder problems--chalky-colored stools, stomach pain just after eating a meal, heartburn, bloating, and upper stomach pain that may spread to your back.

Common side effects of pasireotide may include:

high blood pressure;

abnormal blood test results;

feeling weak or tired;

loss of appetite, nausea, stomach pain or bloating, diarrhea;

headache;

swelling, rapid weight gain;

back pain;

cold symptoms such as stuffy nose and sneezing;

hair loss; or

pain, redness, itching, bruising or bleeding where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Pasireotide

You should not use pasireotide if you are allergic to it.

Tell your doctor if you have ever had:

diabetes, or high blood sugar;

liver disease;

heart problems;

gallstones; or

an electrolyte imbalance (such as low levels of potassium or magnesium in your blood).

It is not known whether pasireotide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Pasireotide may alter hormone levels in a premenopausal woman and may increase the risk of unintended pregnancy. Talk to your doctor about your risk.

You should not breast-feed while using pasireotide.

Relate drugs

How to use Pasireotide

Usual Adult Dose for Cushing's Syndrome:

Intramuscular formulation:Initial dose: 10 mg intramuscularly every 4 weeks (28 days)Maximum dose: 40 mg intramuscularly every 4 weeks (28 days), after 4 months of treatment with 10 mg for patients without normalized 24-hour urinary free cortisol (UFC) levels after 4 months treatment who tolerated the 10 mg doseSuBC UTAneous formulation:Initial dose: 0.6 mg or 0.9 mg subcutaneously twice daily.Maintenance dose: 0.3 to 0.9 mg subcutaneously twice daily.Maximum dose: 0.9 mg subcutaneously twice dailyDuration of therapy: Treatment should be continued as long as benefit is derived.Comments: -Titrate dose based on response and tolerability.-Perform baseline evaluations of fasting plasma glucose, hemoglobin A1c, liver tests, electrocardiogram, serum potassium, and serum magnesium prior to initiating therapy.-Optimize glucose control in poorly controlled diabetics prior to initiating therapy.Use: The treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

Usual Adult Dose for Acromegaly:

Intramuscular formulation:Initial dose: 40 mg, IM, every 28 daysMaximum dose: 60 mg, IM, every 28 days for patients without normalized growth hormone (GH) and/or age and sex adjusted insulin-like growth factor (IGF-1) levels after 3 months treatment who tolerated the 40 mg doseComments:-Titrate dose based on response and tolerability.-Evaluate fasting plasma glucose, HbA1c, liver enzymes, electrocardiogram, and serum magnesium and potassium prior to therapy.-Optimize glucose control in poorly controlled diabetes prior to therapy.Use: Treatment of patients with acromegaly with an inadequate response to surgery and/or for whom surgery is not an option.

Warnings

Pasireotide may lower your cortisol levels. Tell your doctor if you have symptoms such as nausea, vomiting, appetite changes, headache, irritability, confusion, slurred speech, or feeling weak, tired, unsteady, anxious, shaky, or light-headed.

Pasireotide can raise your blood sugar and may cause diabetes. Your blood sugar may need to be tested before and during treatment with pasireotide. Call your doctor if you have increased thirst or urination, tiredness, and weight loss even if you are more hungry than usual.

What other drugs will affect Pasireotide

Pasireotide can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.

Tell your doctor about all your current medicines. Many drugs can affect pasireotide, especially:

Bromocriptine;

cyclosporine;

heart or blood pressure medication; or

medicines to control blood levels of magnesium or potassium.

This list is not complete and many other drugs may affect pasireotide. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.